Skip to main content

Qiagen and Protedyne Team Up to Develop Automated Nucleic Acid Purification System

NEW YORK, June 14 (GenomeWeb News) - Qiagen and Protedyne will collaborate to develop an automated nucleic acid purification system for diagnostic samples, the companies said today.

 

Qiagen, based in Venlo, the Netherlands, will create high-throughput nucleic acid purification procedures for Windsor, Conn.-based Protedyne's BioCube instruments.

 

Both companies plan to make available sample preparation protocols resulting from the collaboration as technical notes.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.